Listen to an audio podcast of the May 11, 2023, FDA Drug Safety Communication on warnings to improve safe use of prescription stimulants used to treat ADHD and other conditions

FDA updating warnings to improve safe use of prescription stimulants used to treat ADHD and other conditions

FDA Drug Safety Podcasts, produced by FDA's Center for Drug Evaluation and Research, provide emerging safety information about drugs in conjunction with the release of Drug Safety Communications. For more information, please visit: www.fda.gov/drugsafetypodcasts

Share FDA updating warnings to improve safe use of prescription stimulants used to treat ADHD and other conditions

Sign up to save your podcasts

FDA updating warnings to improve safe use of prescription stimulants used to treat ADHD and other conditions

FDA updating warnings to improve safe use of prescription stimulants used to treat ADHD and other conditions